The Government Accountability Office, an investigative arm ofCongress, already has been asked to look into whether the FDA muzzledanother staffer who linked antidepressants to raising the odds ofchildren suffering suicidal tendencies.
Whateverthe company's motives, its decision to withdraw Vioxx should castscrutiny on at least two problems inherent in the nation's system forassessing and monitoring drug safety.
Scolnick was the one who had thrown Merck'sresources behind the creation of Vioxx, a painkiller with fewergastrointestinal side effects than traditional drugs.
He thought the concerns, however, would result in more conversationsbetween doctors and patients.
"My stomach was very unsettled," said Martin, a 26-year-old mother inOradell, N.J.
